Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 5, 2019
Patent Application Number
15361571
Date Filed
November 28, 2016
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention is directed to improved therapeutics against receptors within the EGFR/ErbB/HER family that more broadly interfere with multiple members of the HER family (pan-HER inhibition). More particularly, the invention is directed to the use of antibody compositions for human cancer therapy. In vitro studies have shown that the antibody compositions of the invention targeting multiple HER family receptors are superior to antibody compositions targeting only one HER family receptor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
